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Copper is the third most abundant trace element in the body, after iron and zinc, and it is required for the normal function of several important copper enzymes. However, the same element in excess is highly toxic and has detrimental effects. Fine feature is the sparse, coarse, and depigmented est mutation shown by this approach is the deletion of the leader exon (unpublished data).
The remaining genetic defects found in MNK are thus base pair changes or very small rearrangements which can be analysed by various PCR based methodologies. Das 65 and in some cases may be superior to biochemical diagnosis63 (fig 4) . However, when the mutation in the family has not yet been identified, biochemical diagnosis will still be preferred as mutation detection in MD is quite challenging for the reasons mentioned above. Even in the cases where the genetic defect is known, the mutation detection method used has to be optimised before performing the prenatal diagnosis, whereas biochemical diagnosis is already well established. Diagnostic possibilities and risk factors should therefore be evaluated critically for each case.
CARRIER DIAGNOSIS
Carrier determination by measuring radioactive copper accumulation in cultured fibroblasts is possible.'1 59 66 However, owing to random inactivation of one of the X chromosomes, negative results are not reliable and mutation analyses will therefore provide the ultimate proof of carriership54 (figs 4 
and 5).
Identification of carriers will also have an impact on the number of the prenatal diagnoses referred to our institute, as about 80% of the male fetuses tested are not affected, indicating that a substantial number of the females are not carriers. Using mutation analyses we have performed carrier diagnosis in about 15 families and in 1 1 of these families the mother was heterozygous for the mutation found in the index patient (unpublished data).
In families where the mutation is unknown, intragenic polymorphic markers may also enable carrier diagnosis. A BfaI polymorphism has been identified within the coding region of MNK"5 and it is localised to exon 10 (unpublished data). Furthermore, two polymorphic CA repeats within the gene (introns 2 and 5) were identified by us and others67 and these are currently being used for carrier diagnosis in the families where the mutation is as yet unknown (unpublished data).
Treatment of Menkes disease
In MD copper uptake is normal, but a defect in MNK disturbs the intracellular copper homeostasis and copper requiring enzymes cannot receive the copper necessary for their normal function. The objective of a treatment is thus to provide copper to the intracellular compartments where the copper enzymes are synthesised. However, parenteral administration of various copper preparations (as copper sulphate or copper-EDTA) did not produce substantial clinical improvement in MD patients.66
On the other hand, copper-histidine, the physiological copper complex found in human serum," had a positive effect in four unrelated MD patients, who are the oldest surviving patients receiving this therapy.3 [70] [71] [72] [73] They are now alive between the ages of 7 and 19 years with a milder clinical course resembling OHS.
In two of these patients70 71 we have identified the genetic defect and they both have severe mutations (premature stop codons in exon 4 and exon 12) which would have resulted in a progressive clinical course if untreated.77 However, patients receiving copper-histidine after the first few months of age do not benefit in the same way (though survival may be prolonged),4
suggesting that the therapy should be initiated very early, before the occurrence of irreparable neurodegeneration.7476 Studies with the mouse model of MD imply that there is a critical stage in brain development at which copper is essential, suggesting that induced premature delivery of affected infants for early treatment might be beneficial.3
In the four patients mentioned above, though the neurological symptoms improved, the connective tissue abnormalities persisted. As lysyl oxidase is the enzyme involved in cross linking of collagen and elastin in connective tissues, these results suggest that the function of this enzyme does not appear to be corrected with copper-histidine administration. However, as indicated by the improvement of the neurological symptoms, copper seems to be delivered to some of the copper requiring enzymes using copper-histidine.
Wilson disease
Wilson disease (WD) is an autosomal recessive disorder of copper metabolism resulting from the toxic effects of copper, in contrast to MD mimicking copper deficiency ( Despite recent advances, copper homeostasis is still not fully understood. However, to solve this enigma we now have the most necessary tools, the animal models, and simple biological systems such as bacteria and yeast.
